OR WAIT null SECS
The companies plan to collaborate for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
JM Canty International, a fused sight glass company headquartered in Buffalo, NY, and the National Institute for Bioprocessing Research and Training (NIBRT) announced a research collaboration for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
The Enterprise Ireland-funded collaboration will use a Pharmaflow imaging system that will monitor cell viability in real time with high resolution, without the need for a cell stain, according to a Sept. 27, 2019 press release. Cantyvision software will capture information on cell morphology, including roundness and granularity, while remaining non-destructive to the sample because of the constant analysis of bench-top bioreactors.
The research will be led by Michael Butler, a professor at NIBRT, and will include two members of the NIBRT Cell Technology team and a newly appointed post-doctoral researcher.
“This collaboration will enable us to use the high-resolution optical system developed by Canty in advanced monitoring and control protocols for bioprocesses to produce therapeutic proteins and other cellular therapies,” said Butler in the press release.